Mannkind (MNKD) Intrigues Investors; Canadian Pacific Railway (CP) Enough is Enough


The price of MannKind Corp. (Nasdaq:MNKD) shares soared more than 27% in early trade Monday as the company said that it will discuss with the investment community its U.S. strategic commercial approach for Afrezza – (a rapid-acting inhaled insulin) – on April 19, 2016

MNKD is trading at $1.49, up $0.27 (or +22.50%), and 7,928,776 of its shares exchanged hands so far

Mannkind, which focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes, has 428.85M Shares Outstanding and MNKD stock 52-week range is from $0.64 to $7.32 per share



Shares of Canadian Pacific Railway Ltd. (NYSE:CP) surged to touch the $141.07 mark during Monday’s trading session after the company said that it is ending its takeover bid for rail giant Norfolk Southern Corporation (NYSE:NSC).

CP stock is exchanging hands at $139.55, up $4.76 (or +3.53%), and 981,874 shares of the company were traded so far

Canadian Pacific, a transcontinental railway in Canada and the United States, has 153.00M Shares Outstanding and CP stock one-year range is between $97.09 and $198.44 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at